Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rimsza

Showing results (91-100 of 203) with videos related to

Pageof 21
Sort By:
ACS Applied Materials & Interfaces|November 18, 2021
Kinetically Controlled Linker Binding in Rare Earth-2,5-Dihydroxyterepthalic Acid Metal-Organic Frameworks and Its Predicted Effects on Acid Gas AdsorptionSusan E Henkelis, Dayton J Vogel, Peter C Metz, et al.
British Journal of Haematology|August 7, 2018
The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapyHarald Holte, Klaus Beiske, Merrill Boyle, et al.
Science Advances|October 31, 2025
Strain release through hydrogen bond-mediated layer twistingQi Zheng, Boyang Li, Sizhan Liu, et al.
Blood Neoplasia|July 4, 2025
A novel cereblon variant with both exon 8 and 10 deletions in newly diagnosed and relapsed multiple myelomaYuan Xiao Zhu, Soumya Dutta, Gregory J Ahmann, et al.
American Journal of Hematology|December 22, 2017
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806Daniel O Persky, Hongli Li, Lisa M Rimsza, et al.
Ejhaem|September 2, 2022
Transcriptional profiles define drug refractory disease in myelomaYuan Xiao Zhu, Laura A Bruins, Xianfeng Chen, et al.
Blood Advances|June 28, 2023
Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphomaW Richard Burack, Hongli Li, Diana Adlowitz, et al.
American Journal of Clinical Pathology|December 28, 2020
Reactive Eosinophil Proliferations in Tissue and the Lymphocytic Variant of Hypereosinophilic SyndromeRebecca L King, Brent Tan, Fiona E Craig, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group StudyJ W Sweetenham, B Goldman, M L LeBlanc, et al.
American Journal of Clinical Pathology|December 14, 2020
MastocytosisAlexandar Tzankov, Eric Duncavage, Fiona E Craig, et al.
Pageof 21

Showing results (91-100 of 203) with videos related to

Sort By:
Pageof 21
ACS Applied Materials & Interfaces|November 18, 2021
Kinetically Controlled Linker Binding in Rare Earth-2,5-Dihydroxyterepthalic Acid Metal-Organic Frameworks and Its Predicted Effects on Acid Gas AdsorptionSusan E Henkelis, Dayton J Vogel, Peter C Metz, et al.
British Journal of Haematology|August 7, 2018
The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapyHarald Holte, Klaus Beiske, Merrill Boyle, et al.
Science Advances|October 31, 2025
Strain release through hydrogen bond-mediated layer twistingQi Zheng, Boyang Li, Sizhan Liu, et al.
Blood Neoplasia|July 4, 2025
A novel cereblon variant with both exon 8 and 10 deletions in newly diagnosed and relapsed multiple myelomaYuan Xiao Zhu, Soumya Dutta, Gregory J Ahmann, et al.
American Journal of Hematology|December 22, 2017
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806Daniel O Persky, Hongli Li, Lisa M Rimsza, et al.
Ejhaem|September 2, 2022
Transcriptional profiles define drug refractory disease in myelomaYuan Xiao Zhu, Laura A Bruins, Xianfeng Chen, et al.
Blood Advances|June 28, 2023
Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphomaW Richard Burack, Hongli Li, Diana Adlowitz, et al.
American Journal of Clinical Pathology|December 28, 2020
Reactive Eosinophil Proliferations in Tissue and the Lymphocytic Variant of Hypereosinophilic SyndromeRebecca L King, Brent Tan, Fiona E Craig, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group StudyJ W Sweetenham, B Goldman, M L LeBlanc, et al.
American Journal of Clinical Pathology|December 14, 2020
MastocytosisAlexandar Tzankov, Eric Duncavage, Fiona E Craig, et al.
Pageof 21